Guardant Infinity is a novel technology platform that delivers multiomic insights to power multiple precision oncology applications.

*Coming soon: tissue profiling on Guardant Infinity.
†RNA-based fusion data are only for tissue profiling,
not liquid testing.

Quantify cancer

Monitor and measure cancer
across the continuum of care


Methylation-based quantification
of tumor fraction to measure
disease burden

Characterize cancer

Power the discovery of novel biomarkers with breakthrough multiomic insights

Liquid and tissue profiling* that unlocks a multidimensional view of cancer with genomic, epigenomic, and RNA-based fusion data†

Get a more
complete view
of cancer with
Guardant Infinity.